Is Exelixis a Buy?

This biotech might be a one-trick pony for now. But it’s got a great horse to ride. Keith Speights Jun 30, 2019 at 9:15AM Health Care After a dismal performance in 2018 with Exelixis (NASDAQ:EXEL) shares sinking 35%, the biotech stock is doing much better so far this year. But Exelixis still trails behind the…

Better Buy: Intercept Pharmaceuticals vs. CV Sciences

Which stock wins in a battle between an up-and-coming biotech and a hemp CBD leader? Keith Speights Jun 30, 2019 at 2:00PM Health Care Intercept Pharmaceuticals (NASDAQ:ICPT) and CV Sciences (NASDAQOTH:CVSI) have practically nothing in common. Intercept is a biotech focused on developing and marketing liver disease drugs, while CV Sciences is a leader in…

Learn practical machine-learning skills – and get AI into your real-world products and projects

Bag your MCubed discount early-bird tickets now – and join us this autumn Event Most firms don’t have unlimited funds, developers, nor data to throw at a problem. But that doesn’t mean they can’t benefit from machine learning and artificial intelligence. That’s why at our MCubed conference this year, we put the spotlight on how…

Is Editas Medicine a Buy?

High risk? Definitely. But this small biotech also has the potential for high returns over the long run. Keith Speights Jul 7, 2019 at 7:32AM Health Care It wasn’t all that long ago that CRISPR gene editing generated a huge buzz in investing circles. The technology, which uses bacterial enzymes to cut DNA sequences, was…

Biotech Investors Are Flocking to Paris

iStock Ask a summer tourist the prime attraction of Paris and the apt response will be the museums, the restaurants and the shopping.  But for investors around the globe the answer is HealthTech Investor Days, an event sponsored by France Biotech, an association of French entrepreneurs in the life sciences. […]

Ex-FDA chief Scott Gottlieb just joined the board of $240 billion drugmaker Pfizer

Scott Gottlieb, the former FDA commissioner, is joining the board of directors at pharmaceutical company Pfizer.Gottlieb is the latest former regulator to join the board of a pharma company.Visit Business Insider’s homepage for more stories. Former FDA Commissioner Scott Gottlieb just joined the board of directors at drugmaker Pfizer, about two months after stepping down…

Samsung files patent for foldable AR glasses

The Augmented Reality revolution has probably only just begun as we see more games, apps, smartphone features and devices being released on this platform. Samsung is on board obviously and the latest patent that they have filed is proof that they are exploring even more things related to AR. It looks like they are looking…